| 1/4 | US=59-B / Câncer Maciag P. Imunologia tumoral. In: Brentani MM, Coelho FRG, Kowalski LP. Bases da oncologia. 2ªed. São Paulo: Lemar, 2003. p. 113-35. RESPOSTA IMUNE. CONCEITOS GERAIS; IMUNOLOGIA DE TUMORES; CANCER. INFLAMACAO; CELULAS TUMORAIS |
| 2/4 | US=22 / Urologia Inman BA, Frigola X, Dong H, Yang JC, Kwon ED. Restoring host antitumoral immunity: how coregulatory molecules are changing the approach to the management of renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 367-403. ISBN 978-1-58829-737-2. COESTIMULACAO; INIBICAO; IMUNOLOGIA DE TUMORES; IMMUNOEDITING; IMUNOTERAPIA; LINFOCITOS T; CARCINOMA DE CELULAS RENAIS |
| 3/4 | US=14 / Ginecologia DiSaia PJ. Tumors immunology, host defense mechanisms, and biologic therapy. In: DiSaia PJ, Creasman WT, editors. Clinical gynecologic oncology. 7th ed. Philadelphia: Mosby Elsevier, 2007. p. 593-636. ISBN 978-0-3230-3978-9. IMUNOLOGIA DE TUMORES; MECANISMOS DE DEFESA DO HOSPEDEIRO; TERAPIA BIOLOGICA; FATORES HUMORAIS; CELULAS NATURAL KILLER; IMUNIDADE HUMORAL; CITOCINAS; INTERFERONS; INTERLEUCINAS; FACTOR DE NECROSE TUMORAL; RETINOIDES; TERAPIA ANTIANGIOGENESIS |
| 4/4 | US=57-B / Biol/Mol Weinberg RA. Crowd control: tumor immunology and immunotherapy. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 655-724. ISBN 0-8153-4078-8. IMUNOLOGIA DE TUMORES; IMUNOTERAPIA; MOLECULAS DE ANTICORPO POR NEUTRALIZACAO; LINFOCITOS T CITOTOXICOS; IMUNES ANTI-TUMORAIS, ESENVOLVIMENTO DE RESPOSTAS |